Patents
Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692)
05/2013
05/15/2013EP2590992A2 Mu opioid receptor agonist analogs of the endomorphins
05/15/2013CN103108648A Romidepsin solid forms and uses thereof
05/15/2013CN103102389A Sulfur compounds as inhibitors of Hepatitis C virus NS3 serine protease
05/15/2013CN102167727B Synthesis method of pidotimod
05/14/2013US8440851 Spatially-defined macrocyclic compounds useful for drug discovery
05/14/2013US8440626 Antineoplastic peptides
05/14/2013CA2441562C Short bioactive peptides and methods for their use
05/14/2013CA2376698C Streptogramin derivatives, preparation and compositions containing them
05/10/2013WO2013067357A1 Peptide analogs for treating diseases and disorders
05/10/2013WO2013065832A1 Dpp-4 inhibitor
05/10/2013WO2013064539A1 Paraffin wax
05/10/2013WO2013064455A1 Tyrosine based linkers for the releasable connection of peptides
05/10/2013CA2854289A1 Dpp-4 inhibitor
05/10/2013CA2854175A1 Peptide analogs for treating diseases and disorders
05/10/2013CA2854095A1 Tyrosine based linkers for the releasable connection of peptides
05/10/2013CA2853671A1 Medical use
05/09/2013US20130116192 N-(aminoacyl)-amino compound
05/09/2013US20130116184 RFamide-Related Peptides and Methods Thereof
05/09/2013US20130116169 Inhibitors of serine proteases, particularly hcv ns3-ns4a protease
05/09/2013US20130115635 Epitope tag for affinity-based applications
05/09/2013US20130115190 Hepatitis C Virus Inhibitors
05/08/2013EP2588489A2 Biomimetic peptides for bone augmentation
05/08/2013CN103097516A Culture medium for eukaryotic cells
05/08/2013CN103097397A Mitochondrial penetrating peptides as carriers for anticancer compounds
05/08/2013CN103087313A Amino acid oligomer preparation method
05/08/2013CN103087196A Preparation method of muramyl dipeptide-anti-CD20 immune conjugate and application thereof
05/08/2013CN103087150A Small-molecular affinity peptide and application thereof
05/08/2013CN103087149A Peptide fragment-containing cyanoacrylate derivative as well as preparation method and use thereof
05/08/2013CN103087148A Synthesis method of N-(2)-L-alanyl-L-glutamine
05/08/2013CN103087110A Saw horse carbonyl ruthenium compound and preparation method thereof
05/08/2013CN102286071B Cyclic tetrapeptide compound and preparation method and use thereof
05/07/2013US8436137 Selective anticancer chimeric peptide comprising an EGF receptor-binding peptide and a cytotoxic peptide
05/07/2013US8436136 Peptide complex
05/07/2013US8435955 Antibacterial deodorant
05/07/2013US8435950 Anti-aging peptides and cosmetic and/or pharmaceutical composition containing same
05/07/2013CA2659664C Improved radiation therapy methods
05/02/2013WO2013063120A2 Nmda receptor modulators and uses thereof
05/02/2013US20130109880 Phenyl-n-acyl derivatives of amines and amino acids, a process for the preparation thereof, a pharmaceutical composition and use thereof
05/02/2013US20130108605 Method of ameliorating oxidative stress and supplementing the diet
05/02/2013US20130108562 Cosmetic Composition Containing Oligopeptides
05/02/2013CA2853364A1 Nmda receptor modulators and uses thereof
05/01/2013CN103080300A Dipeptides to enhance yield and viability from cell cultures
05/01/2013CN103074282A Tumor targeted bacterium and bactericide preparation method and metabolic product of tumor targeted bacterium
05/01/2013CN103073618A Preparation method for benzyloxycarbonyl alanyl alanine
05/01/2013CN103073617A N-(2)-L-alanyl-L-glutamine compound
05/01/2013CN103073402A Process for the preparation of 3,3-dimethylbutanal
05/01/2013CN101511860B SMAC peptidomimetics useful as IAP inhibitors
05/01/2013CN101111512B Methods of using macrocyclic modulators of the ghrelin receptor
04/2013
04/30/2013US8431538 HDAC inhibitors and therapeutic methods of using same
04/25/2013WO2013059651A1 Bifunctional compounds
04/25/2013WO2013059071A1 Aromatic-cationic peptides and uses of same
04/25/2013US20130102527 Inhibitors of the trypsin-like site of the proteasome and methods of use thereof
04/25/2013US20130101662 Peptides used in the treatment and/or care of the skin, mucous membranes and/or hair and its use in cosmetic or pharmaceutical compositions
04/25/2013CA2852454A1 Aromatic-cationic peptides and uses of same
04/24/2013EP2583675A1 Use of dipeptidylpeptidase inhibitors to regulate glucose metabolism
04/24/2013EP1293495B1 Process for the preparation of bromoisophthalic acid compounds
04/24/2013CN1869061B Peptidomimetic protease inhibitors
04/24/2013CN103059099A Novel pidotimod crystal form and preparation method thereof
04/24/2013CN102093151B Method for synthesizing amide compounds
04/24/2013CN101855235B Protective skin care tetrapeptides
04/24/2013CN101541784B 丙型肝炎病毒抑制剂 Hepatitis C virus inhibitors
04/24/2013CN101232896B Method of treating or preventing tissue deterioration, injury or damage due to congestive heart failure
04/23/2013US8426592 Histone deacetylases, and uses related thereto
04/23/2013US8426560 Microwave-assisted peptide synthesis
04/23/2013US8426557 IGF-1R binding polypeptides and their use
04/23/2013US8426556 Method of producing FR901228
04/23/2013US8426359 Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
04/23/2013CA2471355C Substituted diketopiperazines as oxytocin antagonists
04/18/2013WO2013055051A1 Peptide nanostructure and a production method therefor
04/18/2013US20130096277 Processes and intermediates
04/18/2013US20130096072 Zymogen Activators
04/18/2013US20130095122 Peptides or Antibodies Which Bind to Melanoma Inhibitory Activity (MIA) Protein
04/18/2013US20130095034 Anti-CD74 Immunoconjugates and Methods
04/18/2013CA2851371A1 Zymogen activators
04/17/2013CN1966516B Nanometre collagen oligopeptide and its producing method
04/17/2013CN103044523A Dexamethasone-RGD polypeptide conjugate, preparation method thereof and application
04/17/2013CN103044522A Polypeptide having high affinity with receptor of integrin alpha v beta3
04/17/2013CN103044521A Aspartase-targeted activated adriamycin derivative as well as preparation method and application thereof
04/17/2013CN102174075B Lipopeptide compound as well as compositions, preparation method and application thereof
04/17/2013CN101921309B L-cystyl-2-L-aspartic tripeptide and derivatives, preparation method and application thereof
04/17/2013CN101709078B Immune-modulating peptide
04/16/2013US8420778 Tripeptides and derivatives thereof for cosmetic application in order to improve skin structure
04/16/2013US8420777 Compounds that inhibit Hsp90 protein-protein interactions with IAP proteins
04/16/2013US8420775 Polypeptides and methods for modulating D1-D2 dopamine receptor interaction and function
04/16/2013US8420095 Antigen-containing microspheres for the treatment of allergies
04/16/2013CA2555036C Antithrombotic compound
04/16/2013CA2498614C Analyzing nerve cell damage
04/11/2013CA2850723A1 Organonitro thioether compounds and medical uses thereof
04/10/2013EP2576609A1 Epitope tag for affinity-based applications
04/10/2013EP2576595A1 Mitochondrial penetrating peptides as carriers for anticancer compounds
04/10/2013EP2576594A1 Mitochondrial penetrating peptides as carriers for antimicrobials
04/10/2013EP2576593A1 Methods for the synthesis of dicarba bridges in peptides
04/10/2013EP2576592A1 Preparation of crystalline ezatiostat hydrochloride ansolvate form d
04/10/2013EP2576591A2 Tablet formulation of ezatiostat
04/10/2013EP2576590A1 Crystalline ezatiostat hydrochloride ansolvate
04/10/2013EP2575849A2 An expeditious synthesis of ubiquitinated peptide conjugates
04/10/2013EP2575467A1 Macrocyclic compounds useful as inhibitors of histone deacetylases
04/10/2013CN103030681A Forced-induced fluorescence color-changing compound and preparation method and application thereof
04/10/2013CN103030680A Novel anti-hepatitis C virus inhibitor and preparation method thereof
04/10/2013CN102060908B Novel synthetic antithrombotic polypeptide, and preparation method and application thereof
1 ... 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 ... 307